Application of metronomic chemotherapy in the treatment of advanced non-small cell lung cancer
10.3760/cma.j.issn.1673-422X.2019.06.013
- VernacularTitle:节拍化疗在晚期非小细胞肺癌治疗中的应用
- Author:
Qingqing ZHU
1
,
2
;
Chao XIE
;
Bao SONG
;
Qiujing ZHANG
;
Jie LIU
Author Information
1. 济南大学山东省医学科学院医学与生命科学学院 250022
2. 山东大学附属山东省肿瘤医院肿瘤内科山东省医学科学院
- Keywords:
Carcinoma,non-small-cell lung;
Chemoradiotherapy;
Drug therapy,combination;
Metronomic chemotherapy;
Vinorelbine
- From:
Journal of International Oncology
2019;46(6):374-377
- CountryChina
- Language:Chinese
-
Abstract:
Metronomic chemotherapy is a brand-new and multi-target chemotherapy strategy.Totally different from the traditional chemotherapy,metronomic chemotherapy can exert synergistic and durable anti-tumor effects via multiple mechanisms,including cytotoxic effect,anti-angiogenesis,immune regulation and so on.Single and combined therapy modes of metronomic oral vinorelbine have good curative effects and safeties for the treatment of advanced non-small cell lung cancer.With the in-depth understanding of metronomic chemotherapy,it will certainly become an important treatment mode for advanced non-small cell lung cancer.